Clinical Trial

Combined Effects of INF and OEP in Patients With Diabetic Peripheral Neuropathy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 10, 2025 (before its estimated January 17, 2026 completion). Its status may not reflect the trial's current state.
Summary
DPN often leads to balance issues, sensory deficits, and chronic pain, which can severely impact daily functioning and independence. INF therapy aims to improve nerve blood flow and alleviate neuropathic symptoms through manual techniques, while the Otago Exercise Program focuses on enhancing strength and balance to reduce fall risk. By comparing these two interventions, this study seeks to identify effective strategies that can improve balance, reduce pain, and enhance the quality of life for individuals suffering from DPN
Trial Details
NCT Number NCT07274735
Lead Sponsor Riphah International University
Conditions Diabetic Peripheral Neuropathy
Enrollment 65 participants
Start Date 2024-10-17
Primary Completion 2026-01-17 (estimated)
Study Completion 2026-01-17 (estimated)
Updated on ClinicalTrials.gov 2025-12-10